Revenue Growth and Recovery
2025 revenue of $994M increased 9% year-over-year (8% constant currency). Excluding a one-time commercial partnership benefit, revenue was $982M, up 7% year-over-year (constant currency), marking the first year of substantial organic growth since 2021.
Strong Margin Expansion
Adjusted EBITDA margin expanded to 21.5% as-reported for 2025 and to 20.7% excluding the one-time benefit (up 360 bps YoY). Q4 adjusted EBITDA margin reached 22.7%, up 420 basis points year-over-year and the sixth consecutive quarter of YoY margin expansion.
Significant EPS and Profitability Improvement
Adjusted EPS grew 38% year-over-year to $1.02 (as-reported) for 2025; excluding the one-time benefit adjusted EPS rose 31% to $0.97. Q4 adjusted diluted EPS was $0.27 (up 35% YoY) and GAAP diluted EPS was $0.19 (up 18% YoY).
Record Cash Generation and Strong Cash Conversion
Generated $237M of free cash flow in 2025 (highest since 2021), up 77% year-over-year. Trailing twelve-month free cash flow conversion was 138%, exceeding the >100% target for the fifth consecutive quarter. Net cash and investments ended the year at $642M.
Aggressive Capital Returns and Buyback Authorization
Returned $206M to shareholders in 2025, including $151M of share repurchases. As of year-end approximately $150M remained on the repurchase authorization and the board approved an additional $500M increase to the authorization.
Product and AI Leadership Momentum
Launched multiple AI-enabled products in 2025 (DataMan 290, In-Sight 8,900, OneVision cloud platform, and SLX solutions) to strengthen position across a $7.0B served market (with $3.2B targeted opportunity). Emphasis on embedded AI and edge/cloud model deployment.
Customer Acquisition and Salesforce Transformation
Acquired ~9,000 new customer accounts in 2025 (three times the rate of 2024). Completed a Salesforce transformation (org, process, product, partners) and launched a redesigned cognex.com to improve lead generation and sales productivity.
Updated Financial Framework and Forward Targets
Raised through-cycle adjusted EBITDA margin target to 25%–31% (from 20%–30%) while maintaining through-cycle revenue CAGR of 13%–14% and >100% free cash flow conversion. Targeting a 25% adjusted EBITDA margin run-rate exiting 2026 and at least 20% adjusted EPS growth for 2026.